Vertex recently said the product may deliver more than $100 million in revenue in the 2025 full year. But it's important to ...

Four autoimmune patients treated to date demonstrate deep B-cell depletion sustained for at least 28 days; initial efficacy ...

Scientists used CRISPR technology to disable the cholesterol gene in a groundbreaking study, though widespread availability ...

Scientists are using CRISPR to fast-track the domestication of a wild fruit. For roughly 10,000 years, farming communities ...

CRISPR has incurred nearly $500 million in losses over the past four quarters. It's burning through cash as the result of its ...

Wondering if CRISPR Therapeutics is still a high risk biotech story or a quietly mispriced opportunity? This breakdown will help you decide whether the current share price makes sense for a long term ...

Earlier in the week, ARK purchased 10,353 shares of CRISPR on Wednesday, valued at $584,530, and 43,333 shares on Tuesday, totaling $2,509,414. This consistent buying pattern suggests a strong ...

Across sectors, tech majors worldwide blurred the line between experimental and practical, pushing the world into a new phase ...

CRISPR biosensors enable real-time health monitoring with attomolar sensitivity, wearable integration, and multiplex ...

Precise tumor diagnosis and treatment require the support of abundant molecular information. However, conventional molecular ...

A CRISPR-edited crop, goldenberries, which is easier to grow could help expand dietary diversity around the world.

CRISPR is one of the most revolutionary technologies of the modern era, and now it's being used to bring back long-lost genes ...